These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36889927)

  • 21. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Implications of Clonal Hematopoiesis.
    Steensma DP
    Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis.
    Snetsinger B; Ferrone CK; Rauh MJ
    Methods Mol Biol; 2019; 2045():167-180. PubMed ID: 30941718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal hematopoiesis and hematological malignancy.
    Dunn WG; McLoughlin MA; Vassiliou GS
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into clonal hematopoiesis and its relation to cancer risk.
    Mitchell SR; Gopakumar J; Jaiswal S
    Curr Opin Genet Dev; 2021 Feb; 66():63-69. PubMed ID: 33422951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in understanding the molecular basis of clonal hematopoiesis.
    Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
    Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal hematopoiesis, somatic mosaicism, and age-associated disease.
    Evans MA; Walsh K
    Physiol Rev; 2023 Jan; 103(1):649-716. PubMed ID: 36049115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal hematopoiesis: Molecular basis and clinical relevance.
    Kunimoto H; Nakajima H
    Leuk Res; 2020 Nov; 98():106457. PubMed ID: 33010619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
    Craven KE; Ewalt MD
    Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin of leukemia: Genetic alterations and inflammatory factors in the development of premalignant clonal hematopoiesis.
    Sjövall D; Staffas A
    Semin Hematol; 2020 Jan; 57(1):7-12. PubMed ID: 32690142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights from Studies of Clonal Hematopoiesis.
    Gibson CJ; Steensma DP
    Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 involvement in clonal hematopoiesis of indeterminate potential.
    Chen S; Liu Y
    Curr Opin Hematol; 2019 Jul; 26(4):235-240. PubMed ID: 31045645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.
    Calvillo-Argüelles O; Jaiswal S; Shlush LI; Moslehi JJ; Schimmer A; Barac A; Thavendiranathan P
    JAMA Cardiol; 2019 Apr; 4(4):380-387. PubMed ID: 30865214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
    Todisco G; Moura PL; Hellström-Lindberg E
    Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].
    van Zeventer IA; Buisman SC; de Graaf AO; de Haan G; Jansen JH; Huls G
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.